A Study to Evaluate Ultrasound of Liver Steatosis

Overview

About this study

The purpose of this study is to evaluate the effectiveness of ultrasound reduction imaging for liver steatosis grading using Proton Density Fat Fraction (PDFF) measured by magnetic resonance imaging (MRI) as the reference standard.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients with clinically indicated MRI PDFF for liver imaging.
Age greater than 18 years old.

Exclusion Criteria:

Age under 18 years old.
Vulnerable subjects such as prisoners and adults lacking capacity to consent.
Patient with liver iron overload which may confound PDFF measurements.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Shigao Chen, Ph.D.	Closed for enrollment	Contact information: Jill Weston (507) 538-4981 Weston.Jill@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Shigao Chen, Ph.D.

Closed for enrollment

Contact information:

Jill Weston

(507) 538-4981

Weston.Jill@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials